A drug with the SMILES CC(=O)c1ccc(N2CCN(S(=O)(=O)c3c(C(=O)N4CCCCC4)c(C)n(C)c3C)CC2)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 6.662\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(=O)c1ccc(N2CCN(S(=O)(=O)c3c(C(=O)N4CCCCC4)c(C)n(C)c3C)CC2)cc1
CC(=O)c1ccc(N2CCN(S(=O)(=O)c3c(C(=O)N4CCCCC4)c(C)n(C)c3C)CC2)cc1
1-[4-[4-[1,2,5-trimethyl-4-(piperidine-1-carbonyl)pyrrol-3-yl]sulfonylpiperazin-1-yl]phenyl]ethanone